Baker Heart and Diabetes Research Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
BMC Cardiovasc Disord. 2023 Feb 3;23(1):63. doi: 10.1186/s12872-023-03060-x.
We sought to apply a simple cardiovascular health tool not requiring laboratory tests (the Fuster-BEWAT score, FBS) to predict subclinical atherosclerosis. This study included 2657 young adults (< 40 years of age). In the prognostic group (n = 894, followed for 13 years until aged 40-50 years at follow-up), the primary outcome was presence of carotid plaque measured by carotid ultrasound at follow-up. Of these 894 participants, 86 (9.6%) had unilateral, and 23 participants (2.6%) had bilateral, carotid plaques at follow-up. The baseline FBS was predictive of carotid plaque at follow-up [odds ratio OR = 0.86 (95% CI 0.77-0.96) per 1-SD increase in FBS], similar to prediction from Pooled Cohort Equation [PCE, OR = 0.72 (0.61-0.85) per 1-SD decrease in PCE]. Risk scores at baseline predicted outcomes more strongly than those at follow-up, and did so independently of any changes over 13 years of follow-up. Similar discrimination for predicting carotid plaque after 13 years was found for both baseline FBS [C-statistic = 0.68 (95% CI 0.62-0.74)] and PCE [C-statistic = 0.69 (95% CI 0.63-0.75)]. Application of this FBS prognostic information to a contemporary cohort of 1763 young adults anticipates the future development of plaque in 305 (17.3%), especially in the 1494 participants (85%) with ≤ 2 metrics of ideal health. In conclusions, FBS measured in young adulthood predicted atherosclerosis 13 years later in middle age, independent of score changes over the follow-up period, emphasizing the importance of early damage to vascular health. FBS may be a simple and feasible risk score for engaging low-risk young people with reduction of future cardiovascular risk.
我们试图应用一种不需要实验室检查的简单心血管健康工具(Fuster-BEWAT 评分,FBS)来预测亚临床动脉粥样硬化。这项研究包括 2657 名年轻人(<40 岁)。在预后组(n=894 例,随访 13 年,直至随访时年龄在 40-50 岁)中,主要结局是通过颈动脉超声在随访时测量颈动脉斑块的存在。在这 894 名参与者中,86 名(9.6%)有单侧颈动脉斑块,23 名(2.6%)有双侧颈动脉斑块。基线 FBS 可预测随访时颈动脉斑块[每增加 1-SD,优势比 OR=0.86(95%置信区间 0.77-0.96)],与 Pooled Cohort Equation [PCE,OR=0.72(0.61-0.85)每减少 1-SD 的预测结果相似]。基线风险评分预测结局的能力强于随访时的评分,且独立于 13 年随访期间的任何变化。基线 FBS [C 统计量=0.68(95%置信区间 0.62-0.74)]和 PCE [C 统计量=0.69(95%置信区间 0.63-0.75)]对预测 13 年后颈动脉斑块具有相似的判别能力。将这种 FBS 预后信息应用于 1763 名年轻成年人的当代队列,预计 305 名(17.3%)成年人未来会发生斑块,尤其是在 1494 名(85%)具有≤2 项理想健康指标的参与者中。总之,成年早期测量的 FBS 可预测 13 年后中年的动脉粥样硬化,独立于随访期间评分的变化,强调了早期血管健康损害的重要性。FBS 可能是一种简单可行的风险评分,可以使低危年轻人参与其中,降低未来的心血管风险。